Abnormal expression of COL1A1 has been reported in several cancers, including hepatocellular carcinoma, ovarian cancer, and colorectal cancer, as well as in GC (Li J. et al., 2016; Zhang et al., 2018; Ma et al., 2019; Li et al., 2020). Here, COL1A1 is linked to gastric cancer.